Biosight raised €12M in a Growth/Late round in May 2016. The company is based in Karmiel, Israel. Investors in the round: Arkin Holdings, Michael Ilan Management and Investments, Primera Capital. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €12M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
